End-stage renal disease in North Africa  by Barsoum, Rashad S.
Kidney International, Vol. 63, Supplement 83 (2003), pp. S111–S114
End-stage renal disease in North Africa
RASHAD S. BARSOUM
Department of Medicine, Cairo University, Cairo, Egypt
End-stage renal disease in North Africa. There are many simi- imposed by the former occupation of individual coun-
larities in the profile of chronic renal disease in the five North tries by the French (Morocco, Algeria, Tunisia), Italians
African countries, reflecting their close resemblance in ethnic (Libya) and British (Egypt). All five countries are clas-background, bioecology and socioeconomic standards. The in-
sified under the “medium-economy” category by Worldcidence of renal disease is much higher than that in the West,
Bank criteria, with a Gross National Income per capitayet the prevalence is relatively lower, which mirrors the inade-
quacy of medical care facilities. The principal causes of end- ranging between US$1180 and US$2090 (averaging
stage chronic renal disease (ESRD) are interstitial nephritis US$1590).
(14 to 32%), often attributed to environmental pollution and in- Information on end-stage renal disease (ESRD) pro-advertent use of medications; glomerulonephritis (11 to 24%),
vided in this article is largely subjective. It is mainlymostly mesangioproliferative and focal segmental sclerosis; di-
based on data obtained from a series of questionnairesabetes (5 to 20%) and nephrosclerosis (5 to 21%). Obstructive/
reflux nephropathy, attributed to urinary schistosomiasis, is addressed to leading nephrologists [1–3]. Additional data
common in Egypt (7%), Libya and Southern Algeria. Primary were obtained from national and regional registries and
urolithiasis is a frequent cause of obstructive nephropathy in
sporadic publications in local or international journals.the western (hyperoxaluria) and middle (cystinuria) regions.
The incidence of tuberculosis is increasing, particularly the
diffuse interstitial and hematogenous forms. It is responsible
EPIDEMIOLOGYalso for 10 to 40% of renal amyloidosis. The latter is also fre-
quently associated with familial Mediterranean fever. Sickle The reported annual incidence of ESRD ranges be-
cell anemia is an important health problem in the west, leading tween 34 and 200 per million population (pmp) [3–6].to a wide range of glomerular and tubulointerstitial nephropa-
The respective prevalence ranges from 30 to 430 patientsthies. Takayasu disease is increasingly recognized as a cause of
pmp (Table 1). Although this wide range may reflect theischemic nephropathy and renovascular hypertension. The man-
agement of ESRD is largely influenced by late referral, co- uncertain credibility of national statistics, it indicates the
morbidities and lack of dialysis facilities. Hemodialysis is the relatively poor renal health care standards in certain
most frequent modality of renal replacement therapy (RRT).
North African countries. Despite the relatively high mor-CAPD is used sporadically. Renal transplantation, largely from
tality, the prevalence of ESRD is increasing. Without anlive (often unrelated) donors, is offered to less than 5% of
patients with ESRD. The reported outcome of RRT generally equivalent increase in transplant activity, it is estimated
conforms with international standards. that the dialysis pools would not reach a steady state be-
fore accommodating eight times the new patient load [2].
The principal causes of chronic renal disease [3–6] are
North Africa is the term commonly used to refer to interstitial nephritis (14 to 32%), glomerulonephritis (11
five countries: Morocco, Algeria, Tunisia, Libya and Egypt, to 24%), diabetes (5 to 20%) and nephrosclerosis (5 to
with a total area of 5.8 million square kilometers. The 21%). Polycystic and other hereditary diseases account
climate is mostly hot and dry in summer and relatively for less than 5% of most series. Longitudinal statistical
warm and humid in winter. The population inhabiting data in Egypt display a growing trend to an even increas-
this region is about 138 million, with an African ethnic ing prevalence of interstitial nephropathies and diabetes
background, intermixed with Barbarian, Arab and Medi- at the expense of glomerulonephritis, thereby approach-
terranean population streams. The prevailing socioeco- ing the pattern found in Western nations.
nomic standards are largely influenced by the Islamic Calculus disease is a particularly common cause of in-
religion, although there are variable Christian and Jewish terstitial nephritis in North Africa. In addition to those
sub-populations. Striking cultural differences have been associated with chronic urinary infection [7], metabolic
stones constitute a significant clinical problem, as in the
case of hyperoxaluria in the Northwest [8] and cystinuriaKey words: progressive renal disease, schistosomiasis, tuberculosis, in-
terstitial nephritis, kidney disease in North Africa, chronic renal disease. in Libya [9].
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Table 1. Estimates of the population kinetics of ESRD in North Africaa
Dialysis pool size
Transplant pool size N
Total GNI ESRD Total patients
population per capita incidence on dialysis Live Cadaver
Country millions US $ per million per million Ref donors donors
Algeria 30.4 1590 34 78.5 [4] 35 0
Egypt 63.8 1490 74 264.0 [3] 3000 4
Libya 5.5 1800 200 30.0 b 135 113
Tunisia 9.6 2090 110 430.0 [3,5] 14 0
Morocco 28.7 1180 60 52.3 [6] 98 8
a Most recently available data, ranging from 1993 to 2002
b El-Faitouri, personal communication, 1993
schistosomiasis used to constitute the major cause of carcinoma, which is often seen in males in their thirties.
interstitial nephropathy in Egypt during the past few Owing to the associated fibrosis, the tumor tends to re-
decades. However, due to effective schistosomiasis con- main localized or to spread by local extension; distant
trol programs this etiology is gradually giving way [3] to metastasis is relatively late [13].
obscure interstitial disease probably related to environ- Schistosoma mansoni also forms granulomata in the
mental pollution [10] and the inadvertent use of drugs. gut mucosa and around the hepatic portal tracts, the
Of the glomerulonephritides, proliferative forms are latter leading to progressive fibrosis, portal hypertension
found in the highest prevalence, reflecting the ecologi- and splenomegaly. Impairment of the hepatic macro-
cally rich environment favoring bacterial and parasitic phage function leads to escape of antigens, generated
infections. Focal and segmental glomerulosclerosis (FSGS) by the adult worms inhabiting the portal veins, into the
is reported in 23 to 34%, mostly clustered in black popu- systemic circulation. Together with specific antibodies,
lations. Conversely, IgA nephropathy is rare, consti- they form immune complexes, which deposit in the glo-
tuting 0.2 to 3.8% of renal biopsies examined by immu- meruli, leading to a limited proliferative lesion. In some
nofluorescence [11, 12]. Genetic factors are probably 15% of patients, the renal lesions tend to progress into
important contributors to this geographical influence. end stage [14]. In those patients there is evidence of in-
creased IgA synthesis as well as impaired excretion due
to impaired hepatic macrophage function. S. mansoni-CLINICAL SYNDROMES OF SPECIAL INTEREST
associated glomerulopathy is responsible for about 2%In addition to the conventional renal disorders en-
of renal failure in the Egyptian dialysis populationcountered elsewhere, there are several diseases that are
[3]. Although the initial lesions may respond to specificdisproportionately highly prevalent in North Africa.
anti-parasitic treatment, advanced lesions do not, nor do
they respond to corticosteroids or immunosuppressiveSchistosomiasis
agents [14].This parasitic disease is responsible for considerable
morbidity in the east of the region, where both S. hema- Tuberculosis
tobium and S. mansoni species cause renal disease. Only
As in many other parts of the world, tuberculosis isS. hematobium is encountered in certain foci in the west-
striking back in North Africa. In addition to the classicalern region.
presentations, two interesting syndromes often encoun-S. hematobium ova lead to a chronic granulomatous
tered in the region deserve mentioning.inflammation of the lower urinary tract, which ultimately
Diffuse interstitial tuberculosis [15]. This form oftenleads to fibrosis and calcification. This results in disorders
presents with proteinuria, which may amount to a ne-of bladder motility, ureteric obstruction and occasionally
phrotic range. Renal biopsy shows a diffuse mononuclearreflux, which lead to back pressure, infection and second-
interstitial infiltration, amidst which the characteristicary stone formation [13]. This kind of scenario is respon-
Langhan’s cells are seen. The lesion responds to anti-sible for about 7% of renal failure in the Egyptian dialysis
tuberculous treatment with complete resolution of pro-population [3]. Early bladder lesions respond well to
teinuria.anti-schistosomal treatment. Late fibrotic lesions of little
Hematogenous dissemination [16]. Up to almost 10%functional consequence may be left untreated, but sig-
patients on regular dialysis present with prolonged py-nificant obstructive cases require operative intervention.
rexia, splenomegaly, proteinuria and microhematuria.A notorious complication of urinary schistosomiasis
Peripheral blood picture shows anemia, thrombocyto-in Egypt, Libya, and southern Algeria is the development
of bladder malignancy. This is usually a squamous cell penia and occasionally leukopenia. No early evidence
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for tuberculosis can be obtained except by DNA typing. Takayasu disease
In later stages the eye grounds show typical tubercles, The diagnosis of renovascular hypertension is less of-
and the chest-X-ray shows the familiar miliary shadows. ten made in North Africa than in Western communities.
Fortunately, most strains encountered in North Africa However, with the improvement of diagnostic tech-
still respond to conventional anti-tuberculous treatment. niques, this condition is becoming increasingly recog-
nized. Of particular interest is the observation that many
Amyloidosis cases indeed are attributed to multiple arteritis, which
The prevalence of amyloidosis among patients at- conforms to the widening clinical and geographical spec-
tending renal clinics in North Africa varies between 4 and trum of Takayasu disease. Clinicopathological studies
9% [3]. Tuberculosis is the primary condition associated are underway to define the epidemiological significance
with renal amyloidosis in 10% (Egypt) to 40% (Algeria, of this syndrome, particularly in relation to associated
Tunisia). Familial Mediterranean Fever is responsible tuberculous infection, as suggested in South Africa [21].
for 11.6 to 30% of cases. Schistosomiasis accounts for 15%
of renal amyloids in Egypt [14]. Hydatid disease has
MANAGEMENT OF ESRDbeen reported as the underlying etiology in 3% of cases
Three features modify the conventional managementin Tunisia and a significant yet undetermined proportion
of chronic renal failure in North Africa, namely the latein Libya [17]. Chronic suppuration continues to be the
diagnosis and/or referral to a specialist, the co-morbidit-major cause in the urban communities throughout North
ies associated with many primary diseases, and the short-Africa. An occasional patient with primary renal amy-
age of funds.loidosis is encountered in every clinical series.
Table 1 displays the numbers of patients on renal dial-
ysis treatment per million inhabitants. As in the rest ofSickle cell anemia
the world, the dialysis pool sizes are largely influencedThis disease is endemic in Africa; its prevalence in
by the wealth of particular communities. The majoritynorthern territories ranges between 8 and 10% of the
of patients are treated by hospital hemodialysis, althoughgeneral population. Genetic studies show that yet a
continuous ambulatory peritoneal dialysis (CAPD) ishigher proportion of the community is at risk. Renal
gaining momentum mainly in Tunisia. Very few patientsmanifestations are rarely encountered in the eastern re-
are on intermittent peritoneal dialysis (IPD) or homegion, yet they are fairly common in the western region.
hemodialysis. From 0 to 47% of patients receive bicar-Sickle cell anemia has been reported to account for up
bonate dialysis and from 0 to 10% are on erythropoietinto 20% of cases of mesangiocapillary glomerulonephri-
therapy [3].tis in Tunisia [18]. Other renal manifestations reported
The transplant activity in North Africa is impressive.from the same country include endocapillary prolifera-
As shown in Table 1, most donors are living, since thetion, membranous nephropathy and glomerular base-
law either does not permit (Egypt, Libya, Algeria) or hasment membrane abnormalities by electron microscopy.
just permitted (Tunisia) cadaver donor transplantation.The associated clinical manifestations include protein-
Live unrelated donor transplantation has been steadilyuria with or without the nephrotic syndrome (2/3 of cases),
increasing in Egypt over the past decade. The outcomegross or microhematuria (57%), hypertension (24%) and
of renal transplantation in terms of patient and graftchronic renal failure (33%) [18].
survival conforms to international standards. The major
cause of patient morbidity and mortality is infection [22].Obscure interstitial nephropathy
The prevalence of chronic interstitial nephropathies Reprint requests to Professor Rashad Barsoum, M.D., Cairo Kidney
Center, PO Box 91 Bab-El-Louk, 11513, Cairo, Egypt.is increasing in most North African countries. Its propor-
E-mail: rbarsoum@msn.comtional contribution to ESRD in Egypt has risen from 13
to 23% over a single decade. The traditional explanations
REFERENCESinclude the abuse of medications and environmental pol-
1. Barsoum RS: Ethical and moral dilemmas arising from uremialution [10], although the epidemiological weight of these
therapy in the Third World – A “KAP” review. Prog Artif Organstwo etiologies has never been adequately assessed. 85:89–96, 1986
An interesting observation reported over the past few 2. Barsoum RS: Dialysis in developing countries, in Replacement of
Renal Function by Dialysis (4th ed), edited by Jacobs C, Kjells-years from Egypt and Tunisia is the high prevalence of
trand CM, Koch KM, Winchester JF, Boston, Kluwer Inc., 1996,anti-Ochratoxin antibodies in the sera of such patients p 1433
[19, 20], which suggests that Balkan Nephropathy has 3. Barsoum RS: End stage renal disease in the developing world.
Artif Organs 26:735–736, 2002already crossed to the South of the Mediterranean. Fur-
4. Rayane T, Haddoum: Chronic renal failure in Algeria. Renal
ther studies are awaited to elucidate the epidemiological replacement therapy strategies and progression. (abstract) Saudi
Kidney Dis Transplant Bull 4(Suppl 1):118, 1993significance of these observations.
Barsoum: ESRD in North AfricaS-114
5. Kamoun A, Jawahdou F, Hachicha J, et al: [Causes of end-stage 14. Barsoum RS: Schistosomal glomerulopathies. (Editorial Review)
Kidney Int 44:1–12, 1993chronic kidney failure in children in Tunisia.] (French) Arch Pediatr
15. Mallinson WJ, Fuller RW, Levison DA, et al: Diffuse interstitial4:196–198, 1997
renal tuberculosis–An unusual cause of renal failure. Q J Med 50:6. Bourquia A: La dialyse au Maroc: Realites et Perspectives. Edited
137–148, 1981by Bourquia A, Casablanca, Edit Consulting, 1996
16. Bourquia A: Current status of treatment for chronic renal insuffi-7. Oussama A, Kzaiber F, Mernari B, et al: Analysis of urinary
ciency in Morocco. Nephrologie 20:75–80, 1999calculi in adults from the Moroccan Medium Atlas by Fourier
17. Shambesh MA, Craig PS, Macpherson CN, et al: An extensivetransform infrared spectrophotometry. Prog Urol 10:404–410, 2000 ultrasound and serologic study to investigate the prevalence of
8. Kamoun A, Daudon M, Zghal A, et al: Primary hyperoxaluria: human cystic echinococcosis in northern Libya. Am J Trop Med
Tunisian experience apropos of 24 pediatric cases. Nephrologie Hyg 60:462–468, 1999
18:59–64, 1997 18. Ben Moussa F, Goucha R, Skhiri H, et al: Glomerulonephritis in
9. Pras E, Kochba I, Lubetzky A, et al: Biochemical and clinical sickle cell anemia (SCA). (abstract) Proc IV African Congress of
studies in Libyan Jewish cystinuria patients and their relatives. Am Nephrology/IV Arab Congress of Nephrology and Renal Trans-
J Med Genet 80:173–176, 1998 plantation, Tunis, April 1995, p C47
19. Wafa EW, Yahya RS, Sobh MA, et al: Human ochratoxicosis and10. Mortada WI, Sobh MA, El-Defrawy MM, Farahat SE: Study of
nephropathy in Egypt: A preliminary study. Hum Exp Toxicol 17:lead exposure from automobile exhaust as a risk for nephrotoxicity
124–129, 1998among traffic policemen. Am J Nephrol 21:274–279, 2001
20. Maaroufi K, Achour A, Betbeder AM, et al: Foodstuffs and11. Barsoum RS, Francis M: Spectrum of glomerulonephritis in
human blood contamination by the mycotoxin ochratoxin A: corre-Egypt. Saudi J Kidney Dis Transplant 11:1–9, 2000
lation with chronic interstitial nephropathy in Tunisia. Arch Tox-12. Abderrahim E, Hedri H, Kheder A, et al: Secondary membrano- icol 69:552–558, 1995
proliferative glomerulonephritis in Tunisia. (abstract) Proc IV Af- 21. Hahn D, Thomson PD, Kala U, et al: A review of Takayasu’s
rican Congress of Nephrology/IV Arab Congress of Nephrology arteritis in children in Gauteng, South Africa. Pediatr Nephrol 12:
and Renal Transplantation, Tunis, April 1995, p C44 668–675, 1998
13. Barsoum RS: Urinary schistosomiasis. Am J Kidney Dis 32:xliii– 22. Barsoum RS: Renal transplantation in a developing country. The
Egyptian 17-year experience. Afr J Health Sci 1:30–36, 1994xlvi, 1998
